Navigation Links
Pacira Pharmaceuticals, Inc. Announces New Data Demonstrating Longer Time to First Opioid Use and Reduction in Opioid-Related Adverse Events With EXPAREL™ Compared to Bupivacaine HCl
Date:10/19/2011

ic option for physicians and their patients, should it be approved by the FDA at the end of October."

About Pacira

Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, manufacture and commercialization of novel pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. In December 2010, Pacira announced that its New Drug Application (NDA) for EXPAREL (bupivacaine liposome extended-release injectable suspension), the company's most advanced investigational product candidate, had been accepted for filing by the U.S. Food and Drug Administration (FDA). The FDA has assigned a Prescription Drug User Fee Act (PDUFA) goal date of October 28, 2011 for the review of the EXPAREL NDA. EXPAREL is a bupivacaine-based product and has completed extensive Phase 3 clinical development for postsurgical analgesia by infiltration. EXPAREL consists of bupivacaine encapsulated in DepoFoam, which is designed to address the limitations of widely used medications by enhancing their dosing and/or administration profile. Additional information about Pacira is available at www.pacira.com.

About EXPAREL™

EXPAREL (bupivacaine liposome extended-release injectable suspension) is Pacira's proprietary drug candidate consisting of bupivacaine encapsulated in DepoFoam®, both of which are currently used separately in FDA-approved products. Bupivacaine is a well-characterized anesthetic/analgesic that has an established safety profile with more than 20 years of use in the United States. Market data indicate that there is an unmet medical need for a longer-acting anesthetic/analgesic for postsurgical pain management. Several Phase 2 and Phase 3 clinical trials have been completed for EXPAREL and suggest statistically significant reduction of pain in soft tissue and orthopedic surgery i
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pacira Pharmaceuticals, Inc. Announces Key EXPAREL™ Data to be Presented at American College of Surgeons 97th Annual Clinical Congress
2. Pacira Pharmaceuticals, Inc. Announces Efficacy and Safety of EXPAREL™ Highlighted at "Hot Topics in Plastic Surgery" Panel at the 2011 Annual Meeting of the American Society of Plastic Surgeons
3. Pacira Pharmaceuticals, Inc. to Present at UBS Global Life Sciences Conference
4. Pacira Pharmaceuticals, Inc. Expands EXPAREL™ Commercial Team Infrastructure
5. Pacira Pharmaceuticals, Inc. to Present at Wedbush Securities 2011 Life Sciences Management Access Conference
6. Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results
7. Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society
8. Pacira Pharmaceuticals, Inc. Announces Timing for Second Quarter 2011 Financial Results Webcast and Conference Call
9. Pacira Pharmaceuticals, Inc. Announces Inclusion in Russell 3000 Index
10. Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPAREL™ PDUFA Target Date by Three Months
11. Pacira Pharmaceuticals, Inc. Appoints Two Life Sciences Industry Veterans to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013 Research explores data ... research also   to   be presented ... ), the global specialty biopharmaceutical company, announces that it ... the American Psychiatric Association (APA) 166th Annual Meeting in ... data being presented represent Shire,s ongoing commitment to the ...
(Date:5/17/2013)... MIAMI LAKES, Fla. , May 17, 2013 ... products and delivery technology company that is developing new, patent-pending ... and minerals, announced today that it will hold a business ... on Wednesday, May 22 nd , 2013 at 4:30 PM ... Brian Tuffin will host the call and will ...
(Date:5/17/2013)... , May 17, 2013 ... developer of oral drug delivery systems, announced today that ... cleared the Company,s Investigational New Drug application(IND) for ORMD-0801, ... pleased to have the FDA clearance to proceed," stated ... "The upcoming trial is a major milestone for Oramed ...
Breaking Medicine Technology:Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3
... Aug. 19 Perrigo Company (Nasdaq: PRGO;TASE) announced its ... for its Abbreviated New Drug Application (ANDA) for clobetasol ... owner. On August 17, 2010, Galderma filed ... Court for the Northern District of Texas to prevent ...
... 19 Reportlinker.com announces that a new market ... Strategic Analysis of End-user Preferences in ... http://www.reportlinker.com/p0258289/Strategic-Analysis-of-End-user-Preferences-in-the-US-Stem-Cell-Research-Tools-Markets.html The ... brand perceptions of tools and technologies currently at ...
Cached Medicine Technology:Perrigo Confirms Filing for Clobetasol Shampoo and Announcement of Patent Infringement Lawsuit by Galderma 2Reportlinker Adds Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets 2Reportlinker Adds Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets 3
(Date:5/19/2013)... May 19, 2013 Passages Malibu, the ... center, has announced this week the launch of a ... brands’ social media channels. “We are always looking ... community and to get feedback regarding sobriety, what’s working ... and co-founder of the Passages Addiction Treatment Centers ...
(Date:5/19/2013)... The AMTC team will be screening local ... Convention & Trade Center on June 1st. Professionals and amateurs, ... are free of charge. , Actors, Models and Talent for ... successful artists and grads like Caitlin Kinney - SYTYCD, ... Chris Young - on his Liquid Neon 2013 Tour, Taylor ...
(Date:5/19/2013)... 2013 The legal team at Pulaski ... a concerted effort to connect women and families coping ... drugs Yaz, Yasmin & Ocella with the legal representation ... on the notorious birth control drugs as well as ... , Yaz, Yasmin & Ocella were very popular birth ...
(Date:5/18/2013)... In “Cooking with Spirits for the Spirit: A ... Hall Svisdahl’s new cookbook, readers are transported into the world ... the pickiest eater drool. “I dedicate this book to the ... , Found within the 364 pages of “Cooking with Spirits ... from fast and simple to gourmet. Each recipe greets the ...
(Date:5/18/2013)... 2013) Each year, the American Gastroenterological Association ... and achievements in gastroenterology through its esteemed recognition ... and talented individuals who work tirelessly to advance ... are pleased to announce the 2013 recognition award ... for their tremendous contributions to our field," said ...
Breaking Medicine News(10 mins):Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 3Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 4Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 5
... , ... The National Institutes of Health (NIH) has awarded a “Grand ... Lencz, PhD, at The Feinstein Institute for Medical Research and Ariel Darvasi, ... the genetic basis of schizophrenia. More than two million dollars was awarded ...
... necessary, safe or effective , FRIDAY, Oct. 9 (HealthDay News) ... kids vaccinated against seasonal influenza or H1N1 swine flu this ... is fighting the flu on her own terms -- ... hands frequently, get plenty of sleep and take their "gummies," ...
... Strong Corporate Values, Employee Engagement and Contributions ... Place to Work, , OTTAWA, Oct. 9 /PRNewswire-FirstCall/ - ... radiopharmaceuticals, has been selected as one of Canada,s Top ... largest publisher of employment-related periodicals and online directories. , ...
... Oct. 9 The outcome of the current healthcare ... need to get healthier. From childhood obesity to alarming ... U.S. have been confronted with the consequences of lives ... the healthcare crisis, it,s that over-emphasizing one part of ...
... Genomma Lab Internacional,S.A.B. de C.V. ("Genomma") (BMV: LAB) announced ... Televisa, S.A.B.,(NYSE: TV ; BMV: TLEVISA CPO), which was ... cosmetics and over-the-counter pharmaceuticals,in the United States and Puerto Rico. ... operations during the first quarter of 2010. , ...
... SINGAPORE, Oct. 9 The global diagnostics industry has ... to Frost & Sullivan, the diagnostics and monitoring sectors ... Nitin Naik, Vice President of Frost & Sullivan,s Asia ... in Asia Pacific are projected to provide more growth ...
Cached Medicine News:Health News:Feinstein Investigators Receive Federal GO Grant to Study the Genetics of Schizophrenia 2Health News:'No Flu Shots for My Kids' 2Health News:'No Flu Shots for My Kids' 3Health News:'No Flu Shots for My Kids' 4Health News:MDS Nordion Selected One of Canada's Top 100 Employers for 2010 2Health News:The Holistic Health Show Offers Relief for Healthcare Crisis 2Health News:Singapore Witnesses Healthy Growth in Diagnostics Industry 2Health News:Singapore Witnesses Healthy Growth in Diagnostics Industry 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: